HIV infection and antiretroviral therapy (ART) use are associated with perturbations in
glucose and lipid metabolism. Increasing incidence of diabetes, cardiovascular disease, and …

With the advances in antiretroviral therapy (ART), HIV infection has been transformed into a
chronic medical condition that can be effectively managed like diabetes or hypertension. For …

The treatment of metabolic disease is becoming an increasingly important component of the
long-term management of patients with well controlled HIV on antiretroviral therapy (ART) …

HIV infection and its treatment have been associated with adipose tissue changes and
disorders of glucose and lipid metabolism. The proportion of HIV-infected adults over the …

HIV-infected patients on highly active antiretroviral therapy (HAART) have increased
prevalence of a number of chronic metabolic disorders of multifactorial but unclear etiology …

Objectives With the use of potent antiretroviral therapy in patients with HIV disease, changes
in lipid parameters and glucose homeostasis have been noted. However, these effects have …

HIV-associated morbidity and mortality have declined significantly since the introduction of
highly active antiretroviral therapy (HAART). These developments have allowed an …

Abstract Treatment of HIV infection with highly active antiretroviral therapy (HAART) confers
survival and quality of life benefits. However, these significant benefits are at the cost of …

Over the past 10 years, in conjunction with the broad availability of potent antiretroviral
regimens, the care of human immunodeficiency virus (HIV)–infected patients has shifted …

HIV–infected patients receiving long-term antiretroviral treatment experience a number of
metabolic abnormalities, including lipid abnormalities, dysregulation of glucose metabolism …